Imvax Company

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

Last Funding Type: Series C
Funding Status: Late Stage Venture
Headquarters: Philadelphia, Pennsylvania, United States
Founded Date: 2015-01-01
Last Funding Date: 2020-07-16
Total Funding: 166694660
Employee Number: 11-50
Estimated Revenue: Less than $1M
Investors Number: 6
Industry: Whole-Cell Antigens